Multiple Sclerosis is the most widespread neurological disease which affects about 2-3 millions of people world-wide. The disease most commonly appears in people aged 20 to 40 years, the age group considered as economically active population. MS, after stroke and before Parkinson, is considered as the second chronic and debilitating disease of central nervous system. MS symptoms include: impaired coordination and balance, muscle cramps, fatigue, pain and visual disturbances which could led to movement restriction and, in some cases, hospitalization of patients. Studies have illustrated that patients suffering from MS not only experience a lower quality of life than the general population, but also than those suffering chronic diseases. Extensive
